Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Johnson & Johnson JNJ, under its Innovative Medicine segment, markets several multi-million-dollar drugs that cover a broad ...

Researchers have successfully 3D printed insulin-producing human pancreas cells that could revolutionize treatment for Type 1 ...

A possible no-confidence motion against European Commission President Ursula von der Leyen over her refusal to disclose text ...

AS part of its “Better Days” campaign, Manulife Philippines has partnered with global healthcare brand Pifer to develop and support patient disease awareness and education campaigns as part of its ...

Pfizer's recent trial termination makes it yet another company facing challenges with CD47 studies in oncology.

Over 70 MEPs have backed no-confidence motion against European Commission president, accusing her of violating EU ...

Chairman Jim Jordan subpoenaed former Pfizer executive Dr. Philip Dormitzer for an investigation into delayed COVID-19 ...

This was the stock's second consecutive day of gains.

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.